Targeting colorectal cancer-initiating cells and anti-EGFR therapeutic resistance by manipulating levels of the reactive aldehyde, 4-hydroxynonenal.
Targeting colorectal cancer-initiating cells and anti-EGFR therapeutic resistance by manipulating levels of the reactive aldehyde, 4-hydroxynonenal.
批准号:
302201
负责人:
O'Brien Catherine A
金额:
$21.86万
依托单位国家:
加拿大
项目类别:
Salary Programs
财政年份:
2013
资助国家:
加拿大
项目状态:
已结题
起止时间:
2013-12-01 至 2018-12-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Colorectal cancer (CRC) is the 2nd leading cause of cancer mortality in Canada, with 9,200 deaths annually. We have previously shown that CRCs are initiated and maintained by a subset of colorectal cancer-initiating cells (CC-ICs). There is also increasin
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibition of CBP/p300 bromodomain activity increases chemosensitivity of p53 mutant colorectal cancers through inhibiting p53 aggregation
-
批准号:472399
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2022
-
负责人:O'Brien Catherine A
-
依托单位:
Molecular drivers of the drug tolerant persister state in patient-derived colorectal cancer models
-
批准号:434963
-
项目类别:Operating Grants
-
资助金额:$69.94万
-
财政年份:2020
-
负责人:O'Brien Catherine A
-
依托单位:
Canada Research Chair - Tier 2
-
批准号:415401
-
项目类别:
-
资助金额:$43.71万
-
财政年份:2019
-
负责人:O'Brien Catherine A
-
依托单位:
Colorectal cancer stem cell plasticity: A novel therapeutic target
-
批准号:334266
-
项目类别:Operating Grants
-
资助金额:$88.93万
-
财政年份:2015
-
负责人:O'Brien Catherine A
-
依托单位:
Targeting colorectal cancer-initiating cells and anti-EGFR therapeutic resistance by manipulating levels of the reactive aldehyde, 4-hydroxynonenal
-
批准号:281581
-
项目类别:Operating Grants
-
资助金额:$45.58万
-
财政年份:2013
-
负责人:O'Brien Catherine A
-
依托单位: